Trexquant Investment’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,821
Closed -$874K 1872
2022
Q4
$874K Sell
23,821
-13,505
-36% -$534K 0.02% 697
2022
Q3
$1.76M Buy
37,326
+34,508
+1,225% +$2.23M 0.06% 380
2022
Q2
$202K Sell
2,818
-21,749
-89% -$1.59M 0.01% 1352
2022
Q1
$1.99M Buy
+24,567
New +$2.08M 0.09% 262
2018
Q1
Sell
-9,128
Closed -$398K 1464
2017
Q4
$398K Buy
9,128
+3,258
+56% +$152K 0.04% 613
2017
Q3
$307K Buy
+5,870
New +$327K 0.08% 459
2016
Q4
Sell
-12,300
Closed -$548K 1183
2016
Q3
$548K Sell
12,300
-9,900
-45% -$429K 0.12% 280
2016
Q2
$846K Buy
+22,200
New +$975K 0.11% 292
2015
Q4
Sell
-13,800
Closed -$552K 1333
2015
Q3
$552K Buy
+13,800
New +$603K 0.05% 687

Other funds holding SYNH

Trexquant Investment's SYNH Position: Q1 2023 in Review

Trexquant Investment sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 23,821 shares — an estimated $874K sold.

Trexquant Investment first reported a position in SYNH in Q3 2015 and held it in 9 quarters. The position peaked at $1.99M in Q1 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Trexquant Investment reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Trexquant Investment sold 23,821 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $874K.
  • Trexquant Investment first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 9 quarters.
  • Trexquant Investment's Syneos Health, Inc. Class A Common Stock position peaked at $1.99M in Q1 2022.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Trexquant Investment's 13F filing for Q1 2023, filed 15 May 2023.